MedPath

Laboratoire Boreaderme Inc.

🇨🇦Canada
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

2 Phases

Phase 2:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 2
1 (50.0%)

An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis

Phase 2
Conditions
Recurrent Herpes Labialis
Interventions
First Posted Date
2019-06-06
Last Posted Date
2020-09-07
Lead Sponsor
Laboratoire Boreaderme Inc.
Target Recruit Count
164
Registration Number
NCT03977792

Study of a New Topical Natural Health Product for the Treatment of Herpes Labialis

Not Applicable
Conditions
Herpes Labialis
First Posted Date
2015-10-21
Last Posted Date
2017-03-09
Lead Sponsor
Laboratoire Boreaderme Inc.
Target Recruit Count
40
Registration Number
NCT02582086
Locations
🇨🇦

Evalulab Inc, Montréal, Quebec, Canada

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.